These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17584264)

  • 1. Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation.
    Sonel AF; Shalaby A; McConnell JP; Czarnecki T; Hogen S; Zahid M; Amidi M
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):839-44. PubMed ID: 17584264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
    Chan PS; Chow T; Kereiakes D; Schloss EJ; Waller T; Eagle K; Hayward RA; Vijan S
    Arch Intern Med; 2006 Nov; 166(20):2228-33. PubMed ID: 17101941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
    Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery.
    Oscarsson A; Eintrei C; Anskär S; Engdahl O; Fagerström L; Blomqvist P; Fredriksson M; Swahn E
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1071-9. PubMed ID: 15352951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ; Stein KM; Markowitz SM; Mittal S; Shah BK; Morin DP; Zacks ES; Janik M; Ageno S; Mauer AC; Lerman BB; Iwai S
    J Am Coll Cardiol; 2007 Jul; 50(2):166-73. PubMed ID: 17616302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
    Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
    Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
    Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in octogenarians receiving implantable defibrillators.
    Koplan BA; Epstein LM; Albert CM; Stevenson WG
    Am Heart J; 2006 Oct; 152(4):714-9. PubMed ID: 16996846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troponin T elevation after implanted defibrillator discharge predicts survival.
    Blendea D; Blendea M; Banker J; McPherson CA
    Heart; 2009 Jul; 95(14):1153-8. PubMed ID: 19366711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Troponin-T monitoring in outpatients with nonischemic heart failure].
    Pascual-Figal DA; Manzano-Fernández S; Pastor F; Garrido IP; Casas T; Sánchez Mas J; Ansaldo P; Martínez P; Valdés M
    Rev Esp Cardiol; 2008 Jul; 61(7):678-86. PubMed ID: 18590640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the abnormal signal-averaged electrocardiogram predict future appropriate therapy in patients with implantable cardioverter-defibrillators?
    Haghjoo M; Arya A; Parsaie M; Dehghani MR; Sadr-Ameli MA
    J Electrocardiol; 2006 Apr; 39(2):150-5. PubMed ID: 16580410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.